{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:36:01Z","timestamp":1782254161037,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.lungcan.2013.01.003","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T20:16:47Z","timestamp":1359663407000},"page":"106-108","source":"Crossref","is-referenced-by-count":10,"title":["When a thymic carcinoma \u201cbecomes\u201d a GIST"],"prefix":"10.1016","volume":"80","author":[{"given":"Valentina","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Donini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Sergio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Passalacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Buti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Jul 1 (3)","key":"10.1016\/j.lungcan.2013.01.003_bib0005","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ijrobp.2003.11.021","article-title":"Thymic carcinoma: state of the art review","volume":"59","author":"Eng","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Spring (1)","key":"10.1016\/j.lungcan.2013.01.003_bib0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1053\/j.semtcvs.2004.12.001","article-title":"Surgical treatment of thymic tumors","volume":"17","author":"Wright","year":"2005","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"Jun (6)","key":"10.1016\/j.lungcan.2013.01.003_bib0015","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1200\/JCO.1994.12.6.1164","article-title":"Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group","volume":"12","author":"Loehrer","year":"1994","journal-title":"J Clin Oncol"},{"issue":"Spring (1)","key":"10.1016\/j.lungcan.2013.01.003_bib0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/j.semtcvs.2004.11.003","article-title":"Role of chemotherapy in the management of advanced thymic tumors","volume":"17","author":"Evans","year":"2005","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"Nov (5)","key":"10.1016\/j.lungcan.2013.01.003_bib0025","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1309\/CYJH-9RXM-P2PK-120J","article-title":"On the histologic heterogeneity of thymic epithelial neoplasms, impact of sampling in subtyping and classification of thymomas","volume":"114","author":"Moran","year":"2000","journal-title":"Am J Clin Pathol"},{"issue":"Sep (9)","key":"10.1016\/j.lungcan.2013.01.003_bib0030","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1093\/annonc\/mdr626","article-title":"Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors","volume":"23","author":"Schirosi","year":"2012","journal-title":"Ann Oncol"},{"issue":"May (5)","key":"10.1016\/j.lungcan.2013.01.003_bib0035","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1470-2045(07)70141-9","article-title":"Response of thymoma to cetuximab","volume":"8","author":"Farina","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.lungcan.2013.01.003_bib0040","doi-asserted-by":"crossref","first-page":"381s","DOI":"10.1200\/jco.2005.23.16_suppl.7068","article-title":"Phase II trial of gefitinib treatment in advanced thymic malignancies","volume":"23","author":"Kurup","year":"2005","journal-title":"J Clin Oncol"},{"issue":"May 20 (15)","key":"10.1016\/j.lungcan.2013.01.003_bib0045","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1200\/JCO.2010.32.4467","article-title":"Phase II study of belinostat in patients with recurrent or refractory advanced thymic epithelial tumors","volume":"29","author":"Giaccone","year":"2011","journal-title":"J Clin Oncol"},{"issue":"Jan (1)","key":"10.1016\/j.lungcan.2013.01.003_bib0050","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1210\/endo.140.1.6398","article-title":"In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells","volume":"140","author":"Ferone","year":"1999","journal-title":"Endocrinology"},{"issue":"Jan 15 (2)","key":"10.1016\/j.lungcan.2013.01.003_bib0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1200\/JCO.2004.02.047","article-title":"Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial","volume":"22","author":"Loehrer","year":"2004","journal-title":"J Clin Oncol"},{"issue":"Jun 30 (Suppl)","key":"10.1016\/j.lungcan.2013.01.003_bib0060","article-title":"Phase II study of cixutumumab (IMC-A12) in thymic malignancies","author":"Arun Rajan","year":"2012","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.lungcan.2013.01.003_bib0065","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.aanat.2007.05.003","article-title":"Immunohistochemical expression of vascular endothelial growth factor A (VEGF), and its receptors (VEGFR1, 2) in normal and pathologic conditions of the human thymus","volume":"190","author":"Cimpean","year":"2008","journal-title":"Ann Anat"},{"issue":"Sep (3)","key":"10.1016\/j.lungcan.2013.01.003_bib0070","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1067\/mtc.2002.124389","article-title":"Correlation between tumor angiogenesis and invasiveness in thymic epithelial tumors","volume":"124","author":"Tomita","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"Jun (6)","key":"10.1016\/j.lungcan.2013.01.003_bib0075","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/JTO.0b013e3181a52e25","article-title":"Long lasting response to the multikinase inhibitor bay 43-9006 (sorafenib) in a heavily pretreated metastatic thymic carcinoma","volume":"4","author":"Bisagni","year":"2009","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1016\/j.lungcan.2013.01.003_bib0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12032-008-9100-0","article-title":"Response to sorafenib in cisplatin-resistant thymic carcinoma: a case report","volume":"26","author":"Li","year":"2009","journal-title":"Med Oncol"},{"issue":"Jul 13 (2)","key":"10.1016\/j.lungcan.2013.01.003_bib0085","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.bjc.6605740","article-title":"Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience","volume":"103","author":"Strobel","year":"2010","journal-title":"Br J Cancer"},{"issue":"Oct (10)","key":"10.1016\/j.lungcan.2013.01.003_bib0090","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/JTO.0b013e3181b6be57","article-title":"Imatinib mesylate in patients with WHO B3 thymomas and thymic carcinomas","volume":"4","author":"Giaccone","year":"2009","journal-title":"J Thorac Oncol"},{"issue":"Jun 17 (25)","key":"10.1016\/j.lungcan.2013.01.003_bib0095","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1056\/NEJM200406173502523","article-title":"Thymic carcinoma with overexpression of mutated KIT and the response to imatinib","volume":"350","author":"Strobel","year":"2004","journal-title":"N Engl J Med"},{"issue":"Dec (3)","key":"10.1016\/j.lungcan.2013.01.003_bib0100","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.lungcan.2008.03.013","article-title":"Mutational status of EGFR and KIT in thymoma and thymic carcinoma","volume":"62","author":"Yoh","year":"2008","journal-title":"Lung Cancer"},{"issue":"Oct (10 Suppl 4)","key":"10.1016\/j.lungcan.2013.01.003_bib0105","doi-asserted-by":"crossref","first-page":"S291","DOI":"10.1097\/JTO.0b013e3181f209b9","article-title":"Thymic tumors: relevant molecular data in the clinic","volume":"5","author":"Girard","year":"2010","journal-title":"J Thorac Oncol"},{"issue":"Jan (1)","key":"10.1016\/j.lungcan.2013.01.003_bib0110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.lungcan.2010.09.011","article-title":"Promising efficacy of sorafenib in a relapsed thymic carcinoma with C-KIT exon 11 deletion mutation","volume":"71","author":"Disel","year":"2011","journal-title":"Lung Cancer"},{"issue":"Nov 20 (33)","key":"10.1016\/j.lungcan.2013.01.003_bib0115","doi-asserted-by":"crossref","first-page":"e803","DOI":"10.1200\/JCO.2011.36.6427","article-title":"Impressive response with imatinib in a heavily pretreated patient with metastatic c-KIT mutated thymic carcinoma","volume":"29","author":"Buti","year":"2011","journal-title":"J Clin Oncol"},{"issue":"Oct 14 (9544)","key":"10.1016\/j.lungcan.2013.01.003_bib0120","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(06)69446-4","article-title":"Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial","volume":"368","author":"Demetri","year":"2006","journal-title":"Lancet"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500213000093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500213000093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T23:24:27Z","timestamp":1562628267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500213000093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0169500213000093"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2013.01.003","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}